Lineage Cell Therapeutics, a clinical-stage biotechnology company, has announced that the Company has initiated the DOSED (Delivery of Oligodendrocyte Progenitor Cells (OPCs) for Spinal Cord Injury: Evaluation of a Novel Device) clinical study.
NETZSCH Pumps & Systems announces the NEMO R. MY Magnetically Coupled Pump, a pump designed to meet the most demanding requirements of industries requiring leak-free pumping solutions.
Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, is collaborating with Cytiva to provide customers with an integrated offering for optimised biologics production.
Orchestra BioMed Holdings has announced that FDA has approved its Investigational Device Exemption amendment to initiate an updated design of the Company’s planned Virtue SAB in the Treatment of Coronary ISR Trial.
Amerikooler highlights its XPS Insulation, engineered to deliver "unparalleled" thermal performance, durability, and environmental responsibility across a wide range of applications.
The Novo Nordisk Foundation has announced the latest edition of its annual Challenge Programme, where for the first time it is inviting researchers from outside Denmark, in the European Schengen area, Ireland and the UK.
Metrion Biosciences, a preclinical contract research organisation (CRO), has announced the launch of its validated, high-throughput NaV1.9 screening assay to advance discovery and development of novel pain therapeutics.
Thermo Fisher Scientific is employing an enhanced platform technology and a new CHO K-1 cell line that can reduce timelines to Investigational New Drug (IND) filing from 13 to nine months.
Ferrer, a pharmaceutical company with an increasing focus on rare neurological diseases, and Prilenia Therapeutics B.V., a clinical-stage biotech company, have announced the signing of a strategic co-development and license agreement.
PCI Pharma Services – a global contract development and manufacturing organisation (CDMO) focused on innovative biopharma therapies – is acquiring an entire equity stake in Ajinomoto Althea.
